Coregulation of calcium channels and beta-adrenergic receptors in cultured chick embryo ventricular cells

J Clin Invest. 1989 Sep;84(3):817-23. doi: 10.1172/JCI114241.

Abstract

To examine mechanisms whereby the abundance of functional Ca channels may be regulated in excitable tissue, Ca channel number was estimated by binding of the dihydropyridine (DHP) antagonist 3H (+)PN200-110 to monolayers of intact myocytes from chick embryo ventricle. Beta adrenergic receptor properties were studied in cultured myocytes using [3H]CGP12177, an antagonist ligand. Physiological correlates for alterations in DHP binding site number included 45Ca uptake and contractile response to (+)BAYk 8644, a specific L-type Ca channel activator. All binding and physiological determinations were performed in similar intact cell preparations under identical conditions. 4-h exposure to 1 microM isoproterenol reduced cell surface beta-adrenergic receptor number from 44 +/- 3 to 17 +/- 2 fmol/mg (P less than 0.05); DHP binding sites declined in number from 113 +/- 25 to 73 +/- 30 fmol/mg (P less than 0.03). When protein kinase A was activated by a non-receptor-dependent mechanism, DHP binding declined similarly to 68% of control. Exposure to diltiazem, a Ca channel antagonist, for 18-24 h had no effect on number of DHP binding sites. After 4-h isoproterenol exposure, 45Ca uptake stimulated by BAYk 8644 declined from 3.3 +/- 0.2 nmol/mg to 2.9 +/- 0.3 nmol/mg (P less than 0.01) and BAYk 8644-stimulated increase in amplitude of contraction declined from 168 +/- 7 to 134 +/- 11% (P = 0.02). Thus, elevation of [cAMP] in myocytes is associated with a time-dependent decline in Ca channel abundance as estimated by DHP binding and a decline in physiological responses that are in part dependent on abundance of Ca channels. Binding of a directly acting Ca channel antagonist for 18-24 h does not modulate the number of DHP binding sites.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Agonists / metabolism
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Calcium Channel Blockers / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / metabolism
  • Calcium Channels / physiology*
  • Calcium Radioisotopes / metabolism
  • Cells, Cultured
  • Chick Embryo
  • Dihydropyridines / metabolism
  • Heart Ventricles / metabolism
  • Myocardial Contraction / drug effects
  • Phenethylamines / metabolism
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / physiology*
  • Ventricular Function*

Substances

  • Adrenergic beta-Agonists
  • Calcium Channel Blockers
  • Calcium Channels
  • Calcium Radioisotopes
  • Dihydropyridines
  • Phenethylamines
  • Receptors, Adrenergic, beta